# Notice of Intent to Sole Source - EzPlaz

Notice 5dda764058414494a13827d6b4ad2a6e (solicitation HT942726QE015) from DEPT OF DEFENSE, DEFENSE HEALTH AGENCY, posted 2026-09-01, responses due 2026-09-16T19:00:00.000Z. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | 5dda764058414494a13827d6b4ad2a6e |
| Solicitation number | HT942726QE015 |
| Type | Special Notice |
| Agency | DEPT OF DEFENSE |
| Sub-tier | DEFENSE HEALTH AGENCY (DHA) |
| Office | DEFENSE HEALTH AGENCY |
| Posted | 2026-09-01T19:05:10.000Z |
| Response deadline (UTC) | 2026-09-16T19:00:00.000Z |
| Set-aside | - |
| NAICS | 325412 |
| PSC | 6505 |
| Place of performance | MD, USA |
| Award | - |

## Description

The Defense Health Agency (DHA) Contracting Activity (DHACA), on behalf of the DHA’s Portfolio Acquisition Executive Medical Products (PAE MP), intends to issue a firm-fixed price Indefinite Delivery/Indefinite Quantity contract on a sole source basis under the authority of the Revolutionary Federal Acquisition Regulation (FAR) Overhaul, FAR 6.103-1, only one responsible source and no other supplies or services will satisfy agency requirements, to Vascular Solutions LLC, 6420 Sycamore Ct N, Maple Grove, Minnesota 55369-6032. Vascular Solutions, LLC is the only source able to meet the Government’s requirements. The Government has a has a critical requirement for supply of a Food and Drug Administration (FDA) approved Freeze Dried Plasma (FDP) product for transfusion when plasma is required and other plasma products are not available. The FDA approved Vascular Solutions, LLC FDP product, EZPLAZ™, on 29 July 2026. Vascular Solutions LLC holds the first and only FDA-approved (licensed) FPD product on the market. This Notice of Intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Responses must be supported with clear and convincing evidence articulating the ability to provide FDA approved FDP product. Capability statements shall not exceed 5 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract. If no written responses are received by the date listed below, an Indefinite Delivery/Indefinite Quantity contract will be awarded without further remark. Capability statements are due by 3:00 PM local time, 16 September 2026. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: timothy.j.kelly169.civ@health.mil and shannon.p.lertora.civ@health.mil.

## Sources

- View on SAM.gov: https://sam.gov/opp/5dda764058414494a13827d6b4ad2a6e/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Notice of Intent to Sole Source - EzPlaz, SAM.gov contract opportunity 5dda764058414494a13827d6b4ad2a6e." samgovapi.io, https://samgovapi.io/opportunity/5dda764058414494a13827d6b4ad2a6e, data as of 2026-11-14. Primary record: https://sam.gov/opp/5dda764058414494a13827d6b4ad2a6e/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/5dda764058414494a13827d6b4ad2a6e
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot